A detailed history of Advisor Os, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisor Os, LLC holds 5,103 shares of LLY stock, worth $4.06 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
5,103
Previous 4,690 8.81%
Holding current value
$4.06 Million
Previous $4.25 Million 6.45%
% of portfolio
0.47%
Previous 0.48%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $318,893 - $396,488
413 Added 8.81%
5,103 $4.52 Million
Q2 2024

Aug 05, 2024

BUY
$724.87 - $909.04 $115,254 - $144,537
159 Added 3.51%
4,690 $4.25 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $291,362 - $389,801
492 Added 12.18%
4,531 $3.52 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $723,186 - $852,542
1,377 Added 51.73%
4,039 $2.35 Million
Q3 2023

Nov 02, 2023

BUY
$434.7 - $599.3 $105,197 - $145,030
242 Added 10.0%
2,662 $1.43 Million
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $467,185 - $624,681
1,332 Added 122.43%
2,420 $1.13 Million
Q1 2023

Apr 24, 2023

BUY
$310.63 - $364.82 $21,433 - $25,172
69 Added 6.77%
1,088 $373,000
Q4 2022

Jan 31, 2023

BUY
$321.55 - $374.67 $47,589 - $55,451
148 Added 16.99%
1,019 $372,000
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $12,155 - $13,852
41 Added 4.94%
871 $282,000
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $71,580 - $88,956
-305 Reduced 26.87%
830 $237,000
Q4 2021

Feb 04, 2022

BUY
$224.85 - $279.04 $8,544 - $10,603
38 Added 3.46%
1,135 $314,000
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $3,102 - $3,817
-14 Reduced 1.26%
1,097 $253,000
Q2 2021

Aug 10, 2021

BUY
$180.55 - $233.54 $2,527 - $3,269
14 Added 1.28%
1,111 $255,000
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $180,259 - $233,353
1,097 New
1,097 $205,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Advisor Os, LLC Portfolio

Follow Advisor Os, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Os, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Os, LLC with notifications on news.